FDA Approved: RIVAROXABAN — Original Application (Changzhou Pharmaceutical Factory)

View source ↗

Summary

FDA approved the original application for rivaroxaban from Changzhou Pharmaceutical Factory under ANDA216995.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Nonvalvular Atrial Fibrillation
• Pulmonary Embolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)